Filing Details
- Accession Number:
- 0001140361-23-029264
- Form Type:
- 13D Filing
- Publication Date:
- 2023-06-11 20:00:00
- Filed By:
- Sarissa Capital Management
- Company:
- Alkermes Plc. (NASDAQ:ALKS)
- Filing Date:
- 2023-06-12
- SEC Url:
- 13D Filing
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 9)*
| Alkermes Public Limited Company |
| (Name of Issuer) |
| Ordinary shares, $0.01 par value |
| (Title of Class of Securities) |
| G01767105 |
| (CUSIP Number) |
| Mark DiPaolo Senior Partner, General Counsel Sarissa Capital Management LP 660 Steamboat Road Greenwich, CT 06830 203-302-2330 |
| (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
| June 9, 2023 |
| (Date of Event which Requires Filing of this Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f)
or 13d-1(g), check the following box. ☐
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. G01767105 | Page 2 of 4 Pages |
SCHEDULE 13D
This Amendment No. 9 to Schedule 13D (“Amendment No. 9”) relates to ordinary shares, par value $0.01 per share (“Common Stock” and, such shares, the “Shares”), issued by Alkermes Public Limited
Company, a company incorporated under the laws of Ireland (the “Issuer”), and amends the initial statement on Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on May 10, 2021 (the “Initial Schedule 13D”), as amended by
Amendment No. 1 to Schedule 13D filed on May 27, 2021, Amendment No. 2 to Schedule 13D filed on September 10, 2021, Amendment No. 3 to Schedule 13D filed on November 19, 2021, Amendment No. 4 to Schedule 13D filed on January 10, 2022, Amendment
No. 5 to Schedule 13D filed on July 6, 2022, Amendment No. 6 to Schedule 13D filed on October 7, 2022, Amendment No. 7 to Schedule 13D filed on February 6, 2023, and Amendment No. 8 to Schedule 13D filed on June 5, 2023 (the Initial Schedule 13D,
as so amended, the “Schedule 13D”), on behalf of the Reporting Persons, to furnish the additional information set forth herein. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the
Schedule 13D.
Item 4.Purpose
of Transaction.
Item 4 of the Schedule 13D is hereby amended to include the following:
On June 9, 2023, Sarissa Capital issued the press release attached as Exhibit 5 hereto.
Item 7.Material to Be Filed as Exhibits.
Item 7 of the Schedule 13D is hereby amended to include the following:
Exhibit 5 - Press Release, June 9, 2023
| CUSIP No. G01767105 | Page 3 of 4 Pages |
SCHEDULE 13D
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: June 12, 2023
SARISSA CAPITAL MANAGEMENT LP
| By: | /s/ Mark DiPaolo | |
| | Name: Mark DiPaolo | |
| | Title: Senior Partner, General Counsel | |
| /s/Alexander J. Denner | ||
| Alexander J. Denner | ||
| CUSIP No. G01767105 | Page 4 of 4 Pages |
SCHEDULE 13D
INDEX TO EXHIBITS
Exhibit 1 - Form 8-K of the Issuer filed with the U.S. Securities and Exchange
Commission on April 30, 2021 (incorporated by reference in this Schedule 13D)*
Exhibit 2 - Joint Filing Agreement of the Reporting Persons, dated as of May 10, 2021*
Exhibit 3 - Press Release, July 6, 2022*
Exhibit 4 - Press Release, June 5, 2023*
Exhibit 5 - Press Release, June 9, 2023
* Previously filed.